CN101439106A - Medicament for treating apoplexy - Google Patents
Medicament for treating apoplexy Download PDFInfo
- Publication number
- CN101439106A CN101439106A CNA2008100801080A CN200810080108A CN101439106A CN 101439106 A CN101439106 A CN 101439106A CN A2008100801080 A CNA2008100801080 A CN A2008100801080A CN 200810080108 A CN200810080108 A CN 200810080108A CN 101439106 A CN101439106 A CN 101439106A
- Authority
- CN
- China
- Prior art keywords
- medicine
- apoplexy
- radix
- herba
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A medicine for treating apoplexy takes the root of red-rooted salvia, radix notoginseng,rot of peony, earthworm, scorpion, peach seed, safflower, siegesbeckia, encommiae ulmoide, herb of staghorn clubmoss and the like as raw materials. The raw materials are decocted with water, concentrated into thick paste, dried, crashed into medicinal powder, packed into capsules, and then sterilized, thus obtaining capsules. The medicine for treating apoplexy is characterized by precise effect and rapid healing without side effects and anaphylactic reaction, has positive role in reducing disease of rate of apoplexy and guaranteeing health of people. Proved by clinical trial of 1100 apoplexy patients, the medicine has 90 % cure rate.
Description
Technical field
The present invention relates to a kind of medicine, being specifically related to a kind of is the medicine of the treatment apoplexy of feedstock production with the Chinese crude drug, the invention still further relates to the preparation method of this medicine.
Background technology
Acute cerebrovascular disease has another name called apoplexy, apoplexy, is the general name of cerebral vessels disease.Good sending out in middle-aged and elderly people, commonly encountered diseases is because hypertensive arteriosclerosis.Apoplexy is with sudden syncope, syncope, and with facial hemiparalysis, dysphonia, hemiplegia; Or the askew out-of-the-way unsuccessful main performance characteristic of disease that is is only arranged, it is hurried to be characterized in falling ill, and changes rapidly.The M ﹠ M of apoplexy is higher, often leaves sequela; Age of onset also tends to rejuvenation in recent years, is to threaten human life and the great illness of quality of life.
Apoplexy is the card of deficiency in origin and excess in superficiality, is preponderance of either YIN or YANG at this, and mechanism of qi is disorderly contrary; Be designated as fire and wind stirring up each other, expectorant is turbid to be jammed blood-stasis internal-depression.The common cause of disease has is worried angryly, and on the scoop, or addiction to greasy and sweet foods, it is tired to indulge in sensual pleasures, or daily life is careless etc.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine preparation with treatment apoplexy of obvious curative effects.
Medicine of the present invention is that the Chinese medicine by following ratio of weight and number is that crude drug prepares:
Radix Salviae Miltiorrhizae 60～100 Radix Notoginseng 40～60
Radix Paeoniae Rubra 40～60 Pheretimas 40～60
Scorpio 15～30 Semen Persicaes 15～30
Flos Carthami 15～30 Herba Siegesbeckiaes 60～100
The Cortex Eucommiae 30～60 Herba Lycopodiis 25～40
Caulis Spatholobi 30～60 Hirudos 70～90.
The preferred weight portion rate of described each component is:
Radix Salviae Miltiorrhizae 80～90 Radix Notoginseng 30～50
Radix Paeoniae Rubra 30～50 Pheretimas 40～50
Scorpio 15～20 Semen Persicaes 15～20
Flos Carthami 15～20 Herba Siegesbeckiaes 80～90
The Cortex Eucommiae 40～50 Herba Lycopodiis 30～35
Caulis Spatholobi 40～50 Hirudos 70～80.
The medicine of above-mentioned each component can be made said dosage form on any pharmaceuticss such as tablet, pill, granule, capsule, and the preferred dosage form of the present invention is a capsule.
The concrete preparation method of above-mentioned each component being made medicine of the present invention is:
With above-mentioned various medicines according to described parts by weight mix homogeneously, decoct with water 3 times, each 0.5～1 hour, merge 3 times decocting liquid, filter, being condensed into relative density is the thick paste of 1.25～1.3 (60 ℃), after 50～60 ℃ of dryings, be ground into 100～120 purpose medicated powder, sterilization makes the capsule product in incapsulating.
Use medicine capsule treatment apoplexy 1100 examples of the present invention clinically, effective 1045 examples, effective percentage 95% is cured 990 examples, cure rate 90%.
Drug therapy apoplexy of the present invention has the characteristics of precise effects and rapid healing, has no side effect and anaphylaxis, for reducing the apoplexy sickness rate, ensures that people ' s health has positive role.
The specific embodiment
Embodiment 1:
Take by weighing Radix Salviae Miltiorrhizae 100g, Radix Notoginseng 60g, Radix Paeoniae Rubra 60g, Pheretima 60g, Scorpio 30g, Semen Persicae 30g, Flos Carthami 30g, Herba Siegesbeckiae 100g, Cortex Eucommiae 60g, Herba Lycopodii 40g, Caulis Spatholobi 60g, Hirudo 90g mix homogeneously, decoct with water 3 times, each water 2.5Kg decocted 1 hour, 3 decocting liquids is merged filter, being condensed into relative density is the thick paste of 1.25 (60 ℃), after 60 ℃ of dryings, be ground into 120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
It is better that above product is used for the treatment of acute apoplexy effect.
Embodiment 2:
Take by weighing Radix Salviae Miltiorrhizae 60g, Radix Notoginseng 30g, Radix Paeoniae Rubra 30g, Pheretima 40g, Scorpio 15g, Semen Persicae 15g, Flos Carthami 15g, Herba Siegesbeckiae 60g, Cortex Eucommiae 30g, Herba Lycopodii 25g, Caulis Spatholobi 30g, Hirudo 70g mix homogeneously, decoct with water 3 times, each water 2.5Kg decocted 1 hour, 3 decocting liquids is merged filter, being condensed into relative density is the thick paste of 1.25 (60 ℃), after 60 ℃ of dryings, be ground into 120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
It is better that above product is used for the treatment of chronic apoplexy effect.
Claims (4)
1, a kind of medicine for the treatment of apoplexy is that the Chinese medicine by following ratio of weight and number is that crude drug prepares:
Radix Salviae Miltiorrhizae 60～100 Radix Notoginseng 40～60
Radix Paeoniae Rubra 40～60 Pheretimas 40～60
Scorpio 15～30 Semen Persicaes 15～30
Flos Carthami 15～30 Herba Siegesbeckiaes 60～100
The Cortex Eucommiae 30～60 Herba Lycopodiis 25～40
Caulis Spatholobi 30～60 Hirudos 70～90.
2, the medicine of treatment apoplexy according to claim 1 is characterized in that the ratio of weight and number of described each component is:
Radix Salviae Miltiorrhizae 80～90 Radix Notoginseng 30～50
Radix Paeoniae Rubra 30～50 Pheretimas 40～50
Scorpio 15～20 Semen Persicaes 15～20
Flos Carthami 15～20 Herba Siegesbeckiaes 80～90
The Cortex Eucommiae 40～50 Herba Lycopodiis 30～35
Caulis Spatholobi 40～50 Hirudos 70～80.
3, the medicine of treatment apoplexy according to claim 1 is characterized in that said medicine is made capsule.
4, the preparation method of the medicine of the described treatment apoplexy of claim 3, it is characterized in that above-mentioned various medicines according to described parts by weight mix homogeneously, decoct with water 3 times, each 0.5～1 hour, merge 3 times decocting liquid, filter, be condensed into 60 ℃ of relative densities and be 1.25～1.3 thick paste, after 50～60 ℃ of dryings, be ground into 100～120 purpose medicated powder, sterilization makes the capsule product in incapsulating.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008100801080A CN101439106A (en) | 2008-12-12 | 2008-12-12 | Medicament for treating apoplexy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008100801080A CN101439106A (en) | 2008-12-12 | 2008-12-12 | Medicament for treating apoplexy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101439106A true CN101439106A (en) | 2009-05-27 |
Family
ID=40723804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008100801080A Pending CN101439106A (en) | 2008-12-12 | 2008-12-12 | Medicament for treating apoplexy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101439106A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102652768A (en) * | 2012-04-11 | 2012-09-05 | 南京同仁堂药业有限责任公司 | Medicinal composition for relaxing tendons, activating collaterals, promoting blood circulation and removing blood stasis |
| CN103933144A (en) * | 2014-05-20 | 2014-07-23 | 周鹏 | Traditional Chinese medicine preparation for treating cerebral thrombosis and preparation method thereof |
| CN106421364A (en) * | 2016-11-15 | 2017-02-22 | 劳冠阳 | Medicine for treating stroke diseases |
-
2008
- 2008-12-12 CN CNA2008100801080A patent/CN101439106A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102652768A (en) * | 2012-04-11 | 2012-09-05 | 南京同仁堂药业有限责任公司 | Medicinal composition for relaxing tendons, activating collaterals, promoting blood circulation and removing blood stasis |
| CN103933144A (en) * | 2014-05-20 | 2014-07-23 | 周鹏 | Traditional Chinese medicine preparation for treating cerebral thrombosis and preparation method thereof |
| CN106421364A (en) * | 2016-11-15 | 2017-02-22 | 劳冠阳 | Medicine for treating stroke diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104689232A (en) | Traditional Chinese medicine composition for adjusting cardiovascular and cerebrovascular diseases | |
| CN102813839A (en) | Compound medicine for treating cluster headache syndrome | |
| CN102406911A (en) | Chinese medicine preparation for treating coronary heart disease | |
| CN102488812B (en) | Bone fracture oral medicine, preparation method thereof, and application method thereof | |
| CN102274252B (en) | Stauntonvine external applied preparation for treating rheumatoid diseases and preparation method thereof | |
| CN103800795A (en) | Traditional Chinese medicine for treating gastric ulcer | |
| CN101130054A (en) | Traditional Chinese medicine for treating essential resistance of turbid phlegm type vertigo | |
| CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
| CN101439106A (en) | Medicament for treating apoplexy | |
| CN101983695A (en) | Traditional Chinese medicine composition for curing hemiplegia and preparation method thereof | |
| CN103100010A (en) | Drug for treatment of rheumatic arthritis | |
| CN103736047A (en) | Chinese herbal medicine formula for dispelling cold and preparation method thereof | |
| CN102670740B (en) | Drug composition for treating soft tissue injuries and preparation process thereof | |
| CN101396448A (en) | Prescription for treating cervical vertebra disease | |
| CN1814125A (en) | Rehmannia-root preparation | |
| CN1695687A (en) | Medication for treating numbness of the muscles and painful joints | |
| CN104606650A (en) | Traditional Chinese medicine composition treating insomnia | |
| CN108635457A (en) | A kind of Chinese medicine composition and the preparation method and application thereof for treating constipation | |
| CN103272185B (en) | Agent for curing cardiovascular and cerebrovascular diseases | |
| CN1092968C (en) | Pharmaceuticals for treating outer skin blood vessel diease in cold seasons | |
| CN102579617A (en) | Traditional Chinese medicine capsule for treating chronic neck, shoulder, waist and leg pains and processing method of same | |
| CN101874877A (en) | Medicine combination for promoting blood circulation and removing blood stasis and preparation method thereof | |
| CN103638375B (en) | A kind of Chinese medicinal granule for the treatment of rosacea | |
| CN102380050A (en) | Medicament for treating pain in neck, shoulders, low back and legs and preparation method thereof | |
| CN101966304A (en) | Medicament for freeing network vessels and activating blood and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090527 |